Emmessar Biotech & Nutrition informs about board meeting

08 Aug 2022 Evaluate

Emmessar Biotech & Nutrition has informed that the Board of Directors at their meeting held today, has approved and took on record the Un-Audited Financial Results of the Company for the first quarter ended June 30, 2022. The company has enclosed a copy of the said Un-Audited Financial Results along with the Limited Review Report for the first quarter ended June 30, 2022. The results will also be filed in XBRL format. The Board meeting commenced at 12.30 pm and concluded at 1:30 pm.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

31.94 -2.05 (-6.03%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...